Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.3%

1 terminated/withdrawn out of 23 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 15 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
19(100.0%)
19Total
N/A(19)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT03415828Not ApplicableRecruiting

Ethanol Gel Versus Steroid in Refractory Lumbar Discogenic Pain

Role: collaborator

NCT05926739Not ApplicableCompleted

Performance and Safety of the PHENIX LIBERTY, a Medical Device for Electrostimulation and Biofeedback, in the Treatment of Musculoskeletal Disorders

Role: collaborator

NCT05938855Not ApplicableCompleted

Performance and Safety of the PHENIX LIBERTY, a Medical Device for Electrostimulation and Biofeedback, in the Treatment of Pelvic Static Disorders in Women With Urinary Incontinence.

Role: collaborator

NCT06009757Not ApplicableNot Yet Recruiting

GUIDEX® Versus Launcher™ Guiding Catheter in Percutaneous Coronary Intervention (PCI) (GUIDEX_FR)

Role: collaborator

NCT05625815Not ApplicableCompleted

Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots.

Role: collaborator

NCT05793619Not ApplicableCompleted

Tolerance and Performance (Mode of Administration) of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

Role: collaborator

NCT06027697Not Yet Recruiting

Prospective Evaluation of Subchondroplasty in Advanced Knee Osteoarthritis.

Role: collaborator

NCT05495503Not ApplicableCompleted

Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Post-inflamamatory Hyperpigmentation (PIH).

Role: collaborator

NCT05600049Not ApplicableCompleted

Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

Role: collaborator

NCT05886010Not ApplicableUnknown

Performance and Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in th Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation) on the Face and Hands of Asian Ethnicity Skins

Role: collaborator

NCT05883657Not ApplicableUnknown

Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation)

Role: collaborator

NCT05522595Not ApplicableUnknown

Performance and Safety Evaluation of the S360 Medical Device Software.

Role: collaborator

NCT05322668Not ApplicableCompleted

Tolerance of Cyto-selective Difluoroethane-based Cryotherapy

Role: collaborator

NCT05203263Not ApplicableCompleted

Tolerance and Mode of Administration of Cyto-selective Cryotherapy Treatments in Face Brown Spots: Proof of Concept

Role: collaborator

NCT05014321Not ApplicableCompleted

Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots PROOF OF CONCEPT

Role: collaborator

NCT04761276Unknown

Evaluation of Efficacy and Long-term Safety for Lucidis Instant Focus© - PMCF Study Protocol

Role: collaborator

NCT02061852Not ApplicableTerminated

Evaluation of the Safety of the Medical Device Simeox®

Role: collaborator

NCT03410069Not ApplicableCompleted

Monitoring Tissue Perfusion in Critically Ill or High-risk Surgical Patients

Role: collaborator

NCT02841670Completed

Evaluation of Efficacy and Long-term Safety for the InFo - Instant Focus © Lens / PMCF

Role: collaborator

NCT03225729Not ApplicableCompleted

Assessment of CRYOBEAUTY MAINS ET DECOLLETE Versus Liquid Nitrogen Cryotherapy, in the Treatment of Solar Lentigines

Role: collaborator